COMMON STOCK PURCHASE WARRANT CANCER GENETICS, INC.Common Stock Purchase Warrant • January 29th, 2019 • Cancer Genetics, Inc • Services-medical laboratories • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 26, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cancer Genetics, Inc., a Delaware corporation (the “Company”), up to ____ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 29th, 2019 • Cancer Genetics, Inc • Services-medical laboratories • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 28, 2019, between Cancer Genetics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL Cancer Genetics, Inc.Exclusive Agency Agreement • January 29th, 2019 • Cancer Genetics, Inc • Services-medical laboratories • New York
